Amyris, Inc., a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced that Amyris has licensed the Onyx genome engineering platform from Inscripta, a leading gene editing technology company.
October 5, 2021
· 5 min read
